• 1
    Odent MR, Culpin EE, Kimmel T. Pertussis vaccination and asthma: is there a link? JAMA 1994;272:592593.
  • 2
    Kemp T, Pearce N, Fitzharris P, Crane J, Fergusson D, St George I et al. Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology 1997;8:678680.
  • 3
    Hurwitz EL, Morgenstern H. Effects of diphtheria-tetanus-pertussis or tetanus vaccination on allergies and allergy-related respiratory symptoms among children and adolescents in the United States. J Manipulative Physiol Ther 2000;23:8190.
  • 4
    DeStefano F, Gu D, Kramarz P, Truman BI, Iademarco MF, Mullooly JP et al. Childhood vaccinations and risk of asthma. Pediatr Infect Dis J 2002;21:498504.
  • 5
    Nilsson L, Grüber C, Granström M, Björkstén B, Kjellmann N-IM. Pertussis-IgE and atopic disease. Allergy 1998;53:11951201.
  • 6
    Grüber C, Illi S, Lau S, Nickel R, Forster J, Kamin W et al. Transient suppression of atopy in early childhood is associated with high vaccination coverage. Pediatrics 2003;111:e282e288.
  • 7
    Martignon G, Oryszczyn MP, Annesi-Maesano I. Does childhood immunization against infectious diseases protect from the development of atopic disease? Pediatr Allergy Immunol 2005;16:193200.
  • 8
    Aalberse RC, Van Ree R, Dannemann A, Wahn U. IgE antibodies to tetanus toxoid in relation to atopy. Int Arch Allergy Immunol 1995;107:169171.
  • 9
    Dannemann A, Van Ree R, Kulig M, Bergmann RL, Bauer P, Forster J et al. Specific IgE and IgG4 immune responses to tetanus and diphtheria toxoid in atopic and nonatopic children during the first two years of life. Int Arch Allergy Immunol 1996;111:262267.
  • 10
    Nilsson L, Grüber C, Granström M, Björkstén B, Kjellman NI. Pertussis IgE and atopic disease. Allergy 1998;53:11951201.
  • 11
    Rook GA, Stanford JL. Give us this day our daily germs. Immunol Today 1998;19:113116.
  • 12
    Grüber C, Lau S, Dannemann A, Sommerfeld C, Wahn U, Aalberse R. Downregulation of IgE and IgG4 antibodies to tetanus toxoid and diphtheria toxoid by covaccination with cellular Bordetella pertussis vaccine. J Immunology 2001;167:24112417.
  • 13
    Gerhold K, Blümchen K, Bock A, Seib C, Stock P, Kallinich T et al. Endotoxins prevent murine IgE production, T(H)2 immune responses, and development of airway eosinophilia but not airway hyperreactivity. J Allergy Clin Immunol 2002;110:110116.
  • 14
    Lavigne MV, Castro M, Andino J, Manghi M. Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response. Microbes Infect 2004;6:481484.
  • 15
    Hamelmann E, Oshiba A, Loader J, Larsen GL, Gleich G, Lee J et al. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am J Respir Crit Care Med 1997;155:819825.
  • 16
    Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG et al. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997;156:766775.
  • 17
    Wiedermann U, Jahn-Schmid B, Lindblad M, Rask C, Holmgren J, Kraft D et al. Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy. Int Immunol 1999;11:11311138.
  • 18
    Tamura S, Hatori E, Tsuruhara T, Aizawa C, Kurata T. Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B subunit-conjugated ovalbumin. Vaccine 1997;15:225229.
  • 19
    Shi H, Qin S, Huang G, Chen Y, Xiao C, Xu H et al. Infiltration of eosinophils into the asthmatic airways caused by interleukin 5. Am J Respir Cell Mol Biol 1997;16:220224.
  • 20
    Wohlleben G, Erb KJ. Inflammation versus immunoregulation: what is the key to the development of an effective antiallergy vaccine? Pathobiology 20022003;70:270276.
  • 21
    Chuang YH, Chiang BL, Chou CC, Hsieh KH. Immune effector cells induced by complete Freund's adjuvant exert an inhibitory effect on antigen-specific type 2 T helper responses. Clin Exp Allergy 1997;27:315324.
  • 22
    Kim YS, Kwon KS, Kim DK, Choi IW, Lee HK. Inhibition of murine allergic airway disease by Bordetella pertussis. Immunology 2004;112:624630.
  • 23
    Ryan M, Gothefors L, Storsaeter J, Mills KH. Bordetella pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice. Dev Biol Stand 1997;89:297305.
  • 24
    Ausiello CM, Urbani F, La Sala A, Lande R, Cassone A. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect Immun 1997;65:21682174.
  • 25
    Ryan M, Murphy G, Ryan E, Nilsson L, Shackley F, Gothefors L et al. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 1998;93:110.
  • 26
    Mahon BP, Ryan MS, Griffin F, Mills KH. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect Immun 1996;64:52955301.
  • 27
    Heinzel FP, Rerko RM, Ahmed F, Pearlman E. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J Immunol 1995;155:730739.
  • 28
    Snijders A, Kalinski P, Hilkens CM, Kapsenberg ML. High-level IL-12 production by human dendritic cells requires two signals. Int Immunol 1998;10:15931598.
  • 29
    Ennis DP, Cassidy JP, Mahon BP. Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model. Clin Diagn Lab Immunol 2005;12:409417.
  • 30
    Gereda JE, Leung DY, Thatayatikom A, Streib JE, Price MR, Klinnert MD et al. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 2000;355:16801683.
  • 31
    Braun-Fahrländer C, Riedler J, Herz U, Eder W, Waser M, Grize L et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002;347:869877.